Login Create Account

Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

  • Watchlist

    Keep track of companies that you follow and research.

  • 10 Years of Data

    Full access to our data with predictions and indicators that we calculate daily.

  • Screener

    Full access to our screener with tons of custom values and customizable email notifications.

  • XLS Exports

    Excel export of financials and screeners you define and save.

Subscribe now
Screener Weekly Summary

Alignment Healthcare, Inc. ALHC

Healthcare  —  Healthcare Plans
Insider Buys (last 12m)
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Analyst Commentary Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)

Financial statements are limited to most recent four years or quarters for non-powerpack users

Ten years worth of data (where available), most important trends and XLS exports are available for our Powerpack users.

Register an account and get your Powerpack now or Login
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '17
P/E ratio 0.00 0.00 0.00 0.00 ‡‡‡ ‡‡‡ ‡‡‡ —
P/S ratio 0.99 0.79 0.87 1.47 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
P/FCF ratio 34.54 0.00 0.00 0.00 ‡‡‡ ‡‡‡ ‡‡‡ —
P/Operating CF (77.63) (246.40) (8.43) (14.10) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
P/B ratio 21.81 21.26 10.00 8.79 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Price to Tangible BV 27.41 34.86 13.40 10.57 ‡‡‡‡‡ ‡‡‡ ‡‡‡ —
EV/Sales 0.92 0.74 0.78 1.29 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
EV/EBITDA 79.46 0.00 0.00 0.00 ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
EV/Operating CF 25.95 57.49 (24.06) (40.84) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
EV/FCF 32.07 (301.30) (14.96) (26.81) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Quick Ratio 1.54 1.78 1.67 2.18 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Current Ratio 1.71 1.88 1.84 2.37 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Net Debt/EBITDA (6.15) 1.97 1.43 2.27 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Debt/Assets 30.32% 41.10% 27.34% 25.38% ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡
Debt/Equity 1.80 3.18 1.02 0.67 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Asset Turnover 4.27 3.94 2.98 2.27 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Operating CF/Net income (193.27) (0.27) 0.40 0.30 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Capex/Depreciation (0.86) (1.61) (2.00) (1.23) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Depreciation/Fixed assets 0.48 0.38 0.35 0.52 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Interest Coverage 0.00 0.00 0.00 0.00 ‡‡‡ ‡‡‡ ‡‡‡ —
ROE (0.52%) (98.86%) (74.50%) (54.84%) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡ —
ROA (0.08%) (18.64%) (24.15%) (23.65%) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
ROIC 0.00% 0.00% (7,493.96%) 0.00% ‡‡‡ ‡‡‡ ‡‡‡ —
Cash ROIC 6.84% (3.62%) (17.39%) (10.20%) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Return on Tangible Assets (0.16%) (33.97%) (54.33%) (42.51%) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Accounts Receivable Turnover 19.40 19.76 17.15 18.95 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Accounts Payable Turnover 8.44 8.90 7.52 7.23 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Inventory Turnover 0.00 0.00 0.00 0.00 ‡‡‡ ‡‡‡ ‡‡‡ —
Average Days of Receivables 23.41 20.78 23.97 23.64 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Average Days of Payables 53.57 47.30 51.49 59.11 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Days of Inventory on Hand 0.00 0.00 0.00 0.00 ‡‡‡ ‡‡‡ ‡‡‡ —
Research and Development Expense of Revenue 0.00% 0.00% 0.00% 0.00% ‡‡‡ ‡‡‡ ‡‡‡ —
Selling, General and Administrative Expense of Revenue 11.23% 13.74% 16.86% 20.61% ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Intangible Assets out of Total Assets 0.03 0.05 0.07 0.06 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡
Share Based Compensation of Revenue 1.57% 2.63% 3.66% 5.70% ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Graham Net Nets 0.02 (0.01) 0.03 0.07 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Graham Number 0.00 0.00 0.00 0.00 ‡‡‡ ‡‡‡ ‡‡‡ —
Earnings Yield 0.00% (6.04%) (9.31%) (7.06%) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Free Cash Flow Yield 2.90% (0.31%) (6.02%) (3.29%) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Revenue per Share 19.94 14.17 9.79 7.91 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Operating CF per Share 0.71 0.18 (0.32) (0.25) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Capex per Share (0.13) (0.22) (0.19) (0.13) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Free Cash Flow per Share 0.57 (0.03) (0.51) (0.38) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Cash per Share 3.05 2.47 1.71 2.26 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Shareholders Equity per Share 0.91 0.53 0.85 1.32 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Interest Debt per Share 0.00 0.00 0.00 0.00 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Book value per Share 0.91 0.53 0.85 1.32 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Free Cash Flow 113.22 (6.63) (95.18) (69.20) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Working Capital 394.71 309.79 220.52 314.59 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Capital Expenditures (26.71) (41.40) (35.99) (23.77) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Net Current Asset Value 65.07 (19.47) 49.73 149.99 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Average Receivables 203.56 136.83 106.32 75.70 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Average Payables 409.88 270.41 215.67 172.87 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Average Assets 923.92 686.97 612.87 632.38 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Average Common Equity 140.12 129.51 198.69 272.68 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
EV/EBIT 246.15 0.00 0.00 0.00 ‡‡‡ ‡‡‡ ‡‡‡ —
Capex to Sales 0.01 0.02 0.02 0.02 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Net Profit Margin (0.02%) (4.74%) (8.12%) (10.43%) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ —
Price to Operating Income 265.09 0.00 0.00 0.00 ‡‡‡ ‡‡‡ ‡‡‡ —
Columns are period end dates